This Figshare repository contains the full manuscript, all figures, and supplementary data associated with the article published in Cardiovascular Research in 2024. The study investigates the origin a
Fibrosis is the major determinant of morbidity and mortality in patients with nonalcoholic steatohepatitis (NASH) but has no approved pharmacotherapy in part because of incomplete understanding of its
Background: Imbalances in gut microbiota are linked to chronic diseases, including heart failure, where shifts in microbial composition are evident in patients with reduced ejection fraction (HFrEF).